| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |